Photodynamic therapy of human undifferentiated thyroid carcinoma-bearing nude mice using topical 5-aminolevulinic acid

Photomedicine and Laser Surgery

Volumn 23, Issue 2, 2005, Pages 206-211

  Al Watban, Farouk A H ^a   Zhang, X Y ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHEMOTHERAPY; DISEASE CONTROL; PHOTOSENSITIZERS; TUMORS;

THYROID CANCERS; TUMOR SIZE; UNDIFFERENTIATED THYROID CARCINOMA (UTC);

PHOTODYNAMIC THERAPY;

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; DIODE LASER; DRUG EFFICACY; DRUG SAFETY; IRRADIATION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; THYROID CARCINOMA; TUMOR GROWTH; TUMOR VOLUME; UNDIFFERENTIATED CARCINOMA;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; CARCINOMA; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; THYROID NEOPLASMS; TIME FACTORS;

EID: 19344377746     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2005.23.206     Document Type: Article

References (22)

1. Tumor Registry Annual Report. (1998). Oncology Data Unit, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.
2. Gilliland, F.D., Hunt, W.C., Morris, D.M., and Key, C.R. (1997). Prognostic factors for thyroid carcinoma: A population-based study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer 79:564-573.
3. Agrawal, S., Rao, R.S., Parikh, E.M., Parikh, H.K., Borges, A.M., and Sampat, M.B. (1996). Histologic trends in thyroid cancer 1969-1993: A clinic-pathologic analysis of the relative proportion of anaplastic carcinoma of the thyroid. J. Surg. Oncol. 63:251-255.
4. Demeter, J.G., De Jong, S.A., Lawrence, A.M., and Paloyan, E. (1991). Anaplastic thyroid carcinoma: Risk factors and outcome. Surgery 110:956-963.
5. Hiroshimaya, T., Takahashi, H., and Yao, K., et al. (2002). Clinical review of thyroid malignant tumor. Acta Oto-Laryngol. 547(Suppl):85-87.
6. Headar, T., Mor, C., Shvero, J., Levy, R., and Segal, K. (1993). Anaplasic carcinoma of thyroid. Eur. J. Surg. Oncol. 19:511-516.
7. Ain, K.B. (1998). Anaplastic thyroid carcinoma: Behaviour, biology, and therapeutic approaches. Thyroid 8:715-725.
8. Degroot, L., and Zhang, R. (2002). Gene therapy for thyroid cancer: Where do we stand? J. Clin. Endocrinol. Metab. 86: 2923-2928.
9. Al-Watban, F.A.H. (1990). Photodynamic therapy: Tumor volume limitation and tumor response for murine fibrosarcoma. Lasers Surg. Med. 10:165-172.
10. Al-Watban, F.A.H. (1990). Variations in biological activities of HPD in comparison to other dosimetric parameters. Lasers Life Sci. 3:155-166.
11. Al-Watban, F.A.H., King, G., Brannon, R., et al. (1987). Photodynamic therapy: Optimal treatment parameters in murine fibrosarcoma. Lasers Life Sci. 3:55-62.
12. Peng, Q., Warloe, T., and Berg, K., et al. (1997). 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79:2282-2308.
13. Wolf, P., Rieger, E., and Kerl, H. (1993). Topical photodynamic therapy with endogenous porphyrin after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinoma and superficial basal cell carcinoma? J. Am. Acad. Dermatol. 1:17-21.
14. Moorton, C.A., Whitehurst, C., Moseley, H., McColl, J.H., Moore, J.V., and Mackie, R.M. (1996). Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br. J. Dermatol. 5:766-771.
15. Shi, Y.F., Ranjit, S.P., and Zou, M.J., et al. (2003). Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein. Human Gene Ther. 14:1741-1751.
16. Dougherty, T.J. (2002). An update on photodynamic therapy applications. J. Clin. Laser Med. Surg. 20:3-7.
17. Taylor, E.L., and Brown, S.B. (2002). The advantages of aminolevulinic acid photodynamic therapy in dermatology. J. Dermatol. Treat. 13(Suppl 1):3-11.
18. Kennedy, J.C., Pottier, R.H., and Pross, D.C. (1990). Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J. Photochem. Photobiol. 6:143-148.
19. Kennedy, J.C., and Pottier, R.H. (1992). Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. 14:275-292.
20. Hisazumi, H., Naito, K., Misakii, T., Koshida, K., and Yamamoto, H. (1985). An experimental study of photodynamic therapy using a pulsed gold vapor laser, in: Jori G., Perria, C. Photodynamic therapy of tumors and other diseases. Padova: Libreria Progetto Editire. 252-254.
21. Venkatesh, Y.S., Ordonez, N.G., Schultz, P.N., Hickey, R.C., Goepfert, H., and Samaan, N.A. (1990). Anaplastic carcinoma of the thyroid: A clinicopathologic studying of 121 cases. Cancer 66:321-330.
22. Tomayko, M.M., and Reynolds, C.P. (1989). Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24:148-54.